Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TKO Group Holdings (TKO) Cash & Equivalents (2022 - 2025)

TKO Group Holdings (TKO) has disclosed Cash & Equivalents for 4 consecutive years, with $831.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 34.09% to $831.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $831.1 million through Dec 2025, up 34.09% year-over-year, with the annual reading at $831.1 million for FY2025, 34.09% up from the prior year.
  • Cash & Equivalents hit $831.1 million in Q4 2025 for TKO Group Holdings, down from $861.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $861.4 million in Q3 2025 to a low of $180.6 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $445.8 million across 4 years, with a median of $457.4 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: surged 30.61% in 2023 and later skyrocketed 162.8% in 2024.
  • Year by year, Cash & Equivalents stood at $180.6 million in 2022, then soared by 30.61% to $235.8 million in 2023, then surged by 162.8% to $619.8 million in 2024, then soared by 34.09% to $831.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for TKO at $831.1 million in Q4 2025, $861.4 million in Q3 2025, and $535.1 million in Q2 2025.